238 related articles for article (PubMed ID: 33174017)
1. Identification of circulating hub long noncoding RNAs associated with hypertrophic cardiomyopathy using weighted correlation network analysis.
Guo Q; Wang J; Sun R; Gu W; He Z; Chen Q; Liu W; Chen Y; Wang J; Zhang Y
Mol Med Rep; 2020 Dec; 22(6):4637-4644. PubMed ID: 33174017
[TBL] [Abstract][Full Text] [Related]
2. Identification of inflammation‑associated circulating long non‑coding RNAs and genes in intracranial aneurysm rupture‑induced subarachnoid hemorrhage.
Huang L; Li X; Chen Z; Liu Y; Zhang X
Mol Med Rep; 2020 Dec; 22(6):4541-4550. PubMed ID: 33174039
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.
Cao J; Yuan L
Front Cardiovasc Med; 2022; 9():946229. PubMed ID: 35990977
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of the regulatory lncRNA‑miRNA‑mRNA network and drug prediction in patients with hypertrophic cardiomyopathy.
Li J; Wu Z; Zheng D; Sun Y; Wang S; Yan Y
Mol Med Rep; 2019 Jul; 20(1):549-558. PubMed ID: 31180540
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Shao J; Zhang Y; Fan G; Xin Y; Yao Y
BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
[TBL] [Abstract][Full Text] [Related]
6. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy.
Guo L; Cai Y; Wang B; Zhang F; Zhao H; Liu L; Tao L
Eur J Med Res; 2023 Jun; 28(1):205. PubMed ID: 37391825
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel key lncRNAs involved in periodontitis by weighted gene co-expression network analysis.
Jin SH; Zhou RH; Guan XY; Zhou JG; Liu JG
J Periodontal Res; 2020 Jan; 55(1):96-106. PubMed ID: 31512745
[TBL] [Abstract][Full Text] [Related]
9. Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy.
Yang W; Li Y; He F; Wu H
BMC Cardiovasc Disord; 2015 Jul; 15():62. PubMed ID: 26141701
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair
Zhang Y; Zhao J; Jin Q; Zhuang L
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474063
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Circulating Apoptosis- and Autophagy-Related lncRNAs as Diagnostic Markers in Coronary Artery Disease.
Zhang L; Lou D; He D; Wang Y; Wu Y; Cao X; Qu P
Biomed Res Int; 2021; 2021():5517786. PubMed ID: 34513991
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
[TBL] [Abstract][Full Text] [Related]
13. Reconstruction and analysis of potential biomarkers for hypertrophic cardiomyopathy based on a competing endogenous RNA network.
Chen JY; Xie ZX; Dai JZ; Han JY; Wang K; Lu LH; Jin JJ; Xue SJ
BMC Cardiovasc Disord; 2022 Sep; 22(1):422. PubMed ID: 36138345
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.
Sun Y; Xiao Z; Chen Y; Xu D; Chen S
Front Cell Dev Biol; 2021; 9():822465. PubMed ID: 35178407
[No Abstract] [Full Text] [Related]
15. Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.
Ma Z; Wang X; Lv Q; Gong Y; Xia M; Zhuang L; Lu X; Yang Y; Zhang W; Fu G; Ye Y; Lai D
Pharmgenomics Pers Med; 2021; 14():823-837. PubMed ID: 34285551
[TBL] [Abstract][Full Text] [Related]
16. Osteomodulin is a Potential Genetic Target for Hypertrophic Cardiomyopathy.
Guo W; Feng W; Fan X; Huang J; Ou C; Chen M
Biochem Genet; 2021 Oct; 59(5):1185-1202. PubMed ID: 33715137
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Construction of a Circular RNA-Associated Competing Endogenous RNA Network Identified Novel Circular RNAs in Hypertrophic Cardiomyopathy by Integrated Analysis.
Guo Q; Wang J; Sun R; He Z; Chen Q; Liu W; Wu M; Bao J; Liu Z; Wang J; Zhang Y
Front Genet; 2020; 11():764. PubMed ID: 32849787
[TBL] [Abstract][Full Text] [Related]
18. Identification of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA theory reveals functional lncRNAs in hypertrophic cardiomyopathy.
Tao L; Shi J; Huang X; Hua F; Yang L
Exp Ther Med; 2020 Aug; 20(2):1176-1190. PubMed ID: 32742356
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis.
Zhang X; Cui Y; Ding X; Liu S; Han B; Duan X; Zhang H; Sun T
Bioengineered; 2021 Dec; 12(1):1457-1470. PubMed ID: 33949285
[TBL] [Abstract][Full Text] [Related]
20. lncRNA expression profiles and associated ceRNA network analyses in epicardial adipose tissue of patients with coronary artery disease.
Wang QC; Wang ZY; Xu Q; Chen XL; Shi RZ
Sci Rep; 2021 Jan; 11(1):1567. PubMed ID: 33452392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
